Improvement of the therapeutic management of allergic patients in Europe – An expert think tank's position paper on allergen immunotherapy
Respiratory allergies are a major global health issue due to their high prevalence and burden on patients, societies, and the health care system. In addition to symptom-relieving pharmacotherapy, allergen immunotherapy (AIT) is the only disease-modifying treatment option currently available that has...
| Published in: | World Allergy Organization Journal |
|---|---|
| Main Authors: | Oliver Pfaar, MD, Maria Beatrice Bilò, MD, Péter Csonka, MD, Frédéric de Blay, MD, Monika Gappa, MD, Radoslaw Gawlik, MD, Philippe Gevaert, MD, Susanne Halken, MD, Valerie Hox, MD, Jasper Kappen, MD, Irena Krčmová, MD, Guillaume Lezmi, MD, Eloína González-Mancebo, MD, Erik Melén, MD, Javier Domínguez-Ortega, MD, Francesca Puggioni, MD, Sverre Steinsvåg, MD, Margitta Worm, MD, Eike Wüstenberg, MD |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-10-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1939455125000869 |
Similar Items
Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment
by: Erminia Ridolo, MD, PhD, et al.
Published: (2024-10-01)
by: Erminia Ridolo, MD, PhD, et al.
Published: (2024-10-01)
Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023
by: Oliver Pfaar, MD, et al.
Published: (2023-05-01)
by: Oliver Pfaar, MD, et al.
Published: (2023-05-01)
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
by: Oliver Pfaar, MD, PhD, et al.
Published: (2024-01-01)
by: Oliver Pfaar, MD, PhD, et al.
Published: (2024-01-01)
Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study
by: Jan-Alexander Schwab, et al.
Published: (2018-06-01)
by: Jan-Alexander Schwab, et al.
Published: (2018-06-01)
Transition between subcutaneous and sublingual allergen immunotherapy: Recommendations of the Brazilian Association of Allergy and Immunology (ASBAI)
by: Fernando Monteiro Aarestrup, MD, PhD, et al.
Published: (2024-08-01)
by: Fernando Monteiro Aarestrup, MD, PhD, et al.
Published: (2024-08-01)
Efficacy and safety of sublingual immunotherapy using a combination of Dermatophagoides pteronyssinus and Blomia tropicalis extracts in patients with allergic rhinitis: A randomized, double-blind, placebo-controlled trial
by: Priscilla Rios Cordeiro Macedo, MD, MSc, et al.
Published: (2025-02-01)
by: Priscilla Rios Cordeiro Macedo, MD, MSc, et al.
Published: (2025-02-01)
Patient compliance to sublingual immunotherapy for mite-induced allergic rhinitis: A retrospective study
by: Wen-Jin Wan, BN, et al.
Published: (2024-07-01)
by: Wen-Jin Wan, BN, et al.
Published: (2024-07-01)
Efficacy of Japanese cedar pollen sublingual immunotherapy tablets for Japanese cypress pollinosis
by: Tomoya Kurokawa, MD, PhD, et al.
Published: (2023-05-01)
by: Tomoya Kurokawa, MD, PhD, et al.
Published: (2023-05-01)
Minimization of ragweed allergy immunotherapy costs through use of the sublingual immunotherapy tablet in Canadian children with allergic rhinoconjunctivitis
by: Anne K. Ellis, et al.
Published: (2023-01-01)
by: Anne K. Ellis, et al.
Published: (2023-01-01)
CHOICE international survey: Clusters of allergen immunotherapy prescription from French and Spanish cohorts
by: Pablo Rodriguez del Rio, MD, PhD, et al.
Published: (2023-06-01)
by: Pablo Rodriguez del Rio, MD, PhD, et al.
Published: (2023-06-01)
Efficacy and immunological changes of sublingual immunotherapy in pediatric allergic rhinitis
by: Yinhui Zeng, MD, et al.
Published: (2023-07-01)
by: Yinhui Zeng, MD, et al.
Published: (2023-07-01)
Impact on quality of life and safety of sublingual and subcutaneous immunotherapy in children with severe house dust mite and pollen-associated allergic rhinoconjunctivitis
by: Thomas Proctor, et al.
Published: (2020-04-01)
by: Thomas Proctor, et al.
Published: (2020-04-01)
Efficacy and safety of house dust mite sublingual immunotherapy tablets in allergic rhinitis: A systematic review and meta-analysis
by: Prapasri Kulalert, MD, PhD, et al.
Published: (2022-09-01)
by: Prapasri Kulalert, MD, PhD, et al.
Published: (2022-09-01)
Clinical outcomes of allergen immunotherapy in children in Latin America: Treatment with polymerized allergen extracts of Dermatophagoides pteronyssinus and Dermatophagoides farinae
by: Ricardo Cardona-Villa, MD, MSc, et al.
Published: (2025-08-01)
by: Ricardo Cardona-Villa, MD, MSc, et al.
Published: (2025-08-01)
Update about Oralair® as a treatment for grass pollen allergic rhinitis
by: L. Klimek, et al.
Published: (2022-11-01)
by: L. Klimek, et al.
Published: (2022-11-01)
A high‐dose, depigmented polymerized birch pollen extract for subcutaneous allergen immunotherapy has a favourable efficacy/safety ratio
by: Oliver Pfaar, et al.
Published: (2023-11-01)
by: Oliver Pfaar, et al.
Published: (2023-11-01)
Prognostic Impact of Adjuvant Immunotherapy in Patients With Resectable NSCLC After Neoadjuvant Chemoimmunotherapy: A Brief Report
by: Yichen Dong, MD, et al.
Published: (2025-01-01)
by: Yichen Dong, MD, et al.
Published: (2025-01-01)
Oral immunotherapy for food allergy: Translation from studies to clinical practice?
by: Guillaume Pouessel, MD, et al.
Published: (2023-02-01)
by: Guillaume Pouessel, MD, et al.
Published: (2023-02-01)
Comparing the risk of anaphylaxis requiring epinephrine in oral immunotherapy and subcutaneous immunotherapy: A review of recent Canadian real-world literature
by: Uliana Kovaltchouk, MD, FRCPC, et al.
Published: (2023-05-01)
by: Uliana Kovaltchouk, MD, FRCPC, et al.
Published: (2023-05-01)
Intensified Hyposensitization Is an Effective Treatment of Postorgasmic Illness Syndrome (POIS)
by: Joanna Wrotynska-Barczynska, MD, et al.
Published: (2022-04-01)
by: Joanna Wrotynska-Barczynska, MD, et al.
Published: (2022-04-01)
Benefits and risks of the subcutaneous immunotherapy with acari extracts in allergic rhinoconjunctivitis and bronchial asthma
by: Olimpio Rodríguez-Santos, et al.
Published: (2014-12-01)
by: Olimpio Rodríguez-Santos, et al.
Published: (2014-12-01)
CardioMEMS-Guided CAR T Cell Therapy for Lymphoma in a Patient With Anthracycline-Induced Cardiomyopathy
by: Anthony J. Kanelidis, MD, et al.
Published: (2020-09-01)
by: Anthony J. Kanelidis, MD, et al.
Published: (2020-09-01)
The intriguing possibility of using probiotics in allergen-specific immunotherapy
by: Fabiana Furci, MD, et al.
Published: (2023-02-01)
by: Fabiana Furci, MD, et al.
Published: (2023-02-01)
A Phase 1/1B Trial of Pembrolizumab and Trametinib in Advanced NSCLC Enriched for KRAS Mutations
by: Jonathan W. Riess, MD, MS, et al.
Published: (2025-06-01)
by: Jonathan W. Riess, MD, MS, et al.
Published: (2025-06-01)
The impact of neoadjuvant immunotherapy on perioperative outcomes and survival after esophagectomy for esophageal cancerCentral MessagePerspective
by: Lye-Yeng Wong, MD, et al.
Published: (2023-06-01)
by: Lye-Yeng Wong, MD, et al.
Published: (2023-06-01)
A Delayed Presentation of Immune Checkpoint Inhibitor Colitis
by: Alicia Nahhas, et al.
Published: (2025-06-01)
by: Alicia Nahhas, et al.
Published: (2025-06-01)
Brief Report: Clinical Outcomes by Infusion Timing of Immune Checkpoint Inhibitors in Patients With Locally Advanced NSCLC
by: Tsuyoshi Hirata, MD, et al.
Published: (2024-04-01)
by: Tsuyoshi Hirata, MD, et al.
Published: (2024-04-01)
Predicting allergen immunotherapy efficacy based on early maintenance phase response in routine clinical practice
by: Rundong Qin, MD, et al.
Published: (2024-12-01)
by: Rundong Qin, MD, et al.
Published: (2024-12-01)
Abscopal downstaging of intermediate stage hepatocellular via combination cryoablation and immunotherapy with complete pathologic response
by: Ana P. Lucas, MD, et al.
Published: (2024-03-01)
by: Ana P. Lucas, MD, et al.
Published: (2024-03-01)
Combining a WT1 Vaccine (Galinpepimut-S) With Checkpoint Inhibition (Nivolumab) in Patients With WT1–Expressing Diffuse Pleural Mesothelioma: A Phase 1 Study
by: Prashasti Agrawal, MD, et al.
Published: (2025-01-01)
by: Prashasti Agrawal, MD, et al.
Published: (2025-01-01)
Updated grading system for systemic allergic reactions: Joint Statement of the World Allergy Organization Anaphylaxis Committee and Allergen Immunotherapy Committee
by: Paul J. Turner, MD, PhD, et al.
Published: (2024-03-01)
by: Paul J. Turner, MD, PhD, et al.
Published: (2024-03-01)
Allergen immunotherapy in Italy: How, when, and why—A real-world study conducted through a patient association
by: Giovanni Paoletti, MD, et al.
Published: (2025-01-01)
by: Giovanni Paoletti, MD, et al.
Published: (2025-01-01)
Turtle Study: A Phase 2 Study of Durvalumab Plus Carboplatin and Etoposide in Elderly Patients With Extensive-Stage SCLC (LOGiK 2003)
by: Hidenobu Ishii, MD, PhD, et al.
Published: (2025-07-01)
by: Hidenobu Ishii, MD, PhD, et al.
Published: (2025-07-01)
Nicolau syndrome: A case of ischemic necrosis after subcutaneous immunotherapy
by: Joyce Kim, MD, et al.
Published: (2025-02-01)
by: Joyce Kim, MD, et al.
Published: (2025-02-01)
Real-world assessment of anaphylaxis and eosinophilic esophagitis with 12 SQ house dust mite SLIT-tablet sublingual immunotherapy
by: Robert S. Zeiger, MD, PhD, et al.
Published: (2024-08-01)
by: Robert S. Zeiger, MD, PhD, et al.
Published: (2024-08-01)
First-Line Chemo-Immunotherapy in SCLC: Outcomes of a Binational Real-World Study
by: Laura Moliner, MD, et al.
Published: (2025-01-01)
by: Laura Moliner, MD, et al.
Published: (2025-01-01)
Widespread cutaneous eruption following COVID-19 vaccine in the setting of immunotherapy
by: Salma El-Behaedi, BS, et al.
Published: (2022-11-01)
by: Salma El-Behaedi, BS, et al.
Published: (2022-11-01)
Drug-associated abdominal aortitis and retroperitoneal fibrosis after treatment with nivolumab
by: Naomi Wedel, MD, BSc, et al.
Published: (2025-08-01)
by: Naomi Wedel, MD, BSc, et al.
Published: (2025-08-01)
Merkel cell carcinoma originating in the gluteal region
by: Shlomit Fennig, MD, et al.
Published: (2025-08-01)
by: Shlomit Fennig, MD, et al.
Published: (2025-08-01)
Brief Report: Acetaminophen Reduces Neoadjuvant Chemoimmunotherapy Efficacy in Patients With NSCLC by Promoting Neutrophil Extracellular Trap Formation: Analysis From a Phase 2 Clinical Trial
by: Chongwu Li, MD, et al.
Published: (2023-09-01)
by: Chongwu Li, MD, et al.
Published: (2023-09-01)
Similar Items
-
Eosinophilic esophagitis and inhalant antigens: Pointing out the roles of allergic rhinitis, immunotherapy and biologic treatment
by: Erminia Ridolo, MD, PhD, et al.
Published: (2024-10-01) -
Comparison of allergen immunotherapy practice patterns in inhalant allergies in the United States of America and Europe: Similarities and differences 2023
by: Oliver Pfaar, MD, et al.
Published: (2023-05-01) -
Clinical benefits with 300 IR HDM SLIT tablet in Europeans with house dust mite allergic rhinitis: Post hoc analysis of a large phase 3 trial
by: Oliver Pfaar, MD, PhD, et al.
Published: (2024-01-01) -
Intra-Seasonal Initiation of the SQ-Standardised Grass Allergy Immunotherapy Tablet Routinely Applied by Allergy Specialists and General Practitioners with Experience in Treatment of Allergy: A Non-Interventional Observational Study
by: Jan-Alexander Schwab, et al.
Published: (2018-06-01) -
Transition between subcutaneous and sublingual allergen immunotherapy: Recommendations of the Brazilian Association of Allergy and Immunology (ASBAI)
by: Fernando Monteiro Aarestrup, MD, PhD, et al.
Published: (2024-08-01)
